Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current issues in techniques of prostate brachytherapy

D Nori1, J Moni

  • 1Department of Radiation Oncology, New York Hospital, Cornell Medical Center, Flushing 11355, USA.

Seminars in Surgical Oncology
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bullous pemphigoid masquerading as acute radiation dermatitis: case report.

European journal of gynaecological oncology·2002
Same author

The effect of ionizing radiation on intraocular lenses.

International journal of radiation oncology, biology, physics·2001
Same author

Total skin electron beam therapy in the management of cutaneous malignancies.

Clinics in dermatology·2001
Same author

Brachytherapy for carcinoma of the lung.

Oncology (Williston Park, N.Y.)·2001
Same author

Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents.

Circulation·2001
Same author

External beam radiation therapy to prevent postangioplasty dialysis access restenosis: a feasibility study.

Cardiovascular radiation medicine·2001
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Prostate brachytherapy offers superior potency preservation and convenience for prostate cancer patients. This review details its techniques, patient selection, and outcomes, recommending it for good-risk cases.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Urology

Background:

  • Prostate adenocarcinoma is the most common cancer in US men.
  • Brachytherapy provides conformal radiotherapy, dose escalation, and a convenient outpatient procedure.
  • Potency preservation rates with brachytherapy exceed those of external beam radiation therapy (EBRT) and surgery.

Purpose of the Study:

  • To review the advantages and limitations of temporary and permanent prostate brachytherapy.
  • To discuss planning and operative techniques for brachytherapy.
  • To analyze clinical outcomes and patient selection criteria for prostate brachytherapy.

Main Methods:

  • Review of temporary and permanent brachytherapy techniques, including ultrasound/CT-guided transperineal approaches.

Related Experiment Videos

  • Description of basic steps: prostate volume assessment, activity determination, seed placement.
  • Analysis of patient data (stage T2a, 1990-1995) including pre-treatment PSA, Gleason grade, and stage.
  • Main Results:

    • Actuarial 5-year clinical freedom from relapse was 79% and biochemical freedom from relapse was 64% for stage T2a disease.
    • Potency was preserved in over 80% of patients.
    • Patients were categorized into good, intermediate, and poor risk groups based on clinical factors.

    Conclusions:

    • Brachytherapy is recommended as a sole procedure for good-risk prostate cancer patients.
    • A combination of EBRT and brachytherapy is suggested for intermediate-risk patients.
    • Future research should focus on improved imaging and new isotopes.